Page 57 - CPG - Clinical Practice Guidelines - Management of Cancer Pain
P. 57

Management of Cancer Pain (Second Edition)
                  The above meta-analysis  was supported by another meta-analysis
                  of four RCTs comparing medical cannabis and placebo. There was a
                  QRQ VLJQL¿FDQW SDLQ UHGXFWLRQ  :0'            &,       WR       ZLWK
                  D VLJQL¿FDQWO\ KLJKHU ULVN RI WUDQVLHQW FRJQLWLYH LPSDLUPHQW  YRPLWLQJ
                  drowsiness, impaired attention and nausea in those taking medical
                  cannabis. 73, level I

                  A  Malaysian health technology  assessment reported that  current
                  evidence was inadequate to recommend the use of medical cannabis
                  in cancer pain. 74
                  A 2023 meta-analysis on RCTs showed that medical cannabinoids had
                  QR VLJQL¿FDQW GLIIHUHQFH ZLWK SODFHER LQ SDLQ UHGXFWLRQ RU RFFXUUHQFH RI
                  serious AEs. However, the quality of the evidence was graded as low
                  EDVHG RQ *5$'(  75, level I


                  ‡  7KHUH  LV  LQVXI¿FLHQW  HYLGHQFH  WR  IRUPXODWH  D  UHFRPPHQGDWLRQ  IRU
                    medical cannabis use in cancer pain.

                       $QWLFDQFHU 7KHUDS\

                  Radiotherapy, chemotherapy  and hormonal  therapy are important
                  components of  anticancer therapy.  These therapies especially
                  radiotherapy  may  be a strategy  for  multidisciplinary  management of
                  cancer pain.
                  ‡   5DGLRWKHUDS\
                  Radiotherapy  has  been used to  reduce pain and requirements of
                  DQDOJHVLFV LQ V\PSWRPDWLF ERQH PHWDVWDVLV  ([WHUQDO EHDP UDGLRWKHUDS\
                  (EBRT) is a type of radiation that could be given to a single or limited
                  number of sites in a patient.
                  The usual dose-fractionation  of radiotherapy  schedules  for palliation
                  are:
                    {       *\ VLQJOH IUDFWLRQ   GD\
                    {    *\   IUDFWLRQV   ZHHN
                    {    *\    IUDFWLRQV   ZHHNV

                  6LQJOH IUDFWLRQ  (%57  KDV  EHHQ  VKRZQ  WR  EH  DV  HIIHFWLYH  DV  WKH
                  fractionated regime in providing pain relief from bone metastases. Two
                  PHWD DQDO\VHV VKRZHG QR VLJQL¿FDQW GLIIHUHQFH LQ FRPSOHWH DQG RYHUDOO
                  response rates for pain control between single and multiple fractions
                  of radiotherapy in painful uncomplicated bone metastases. However,
                  WKH  WZR  UHYLHZV  GHPRQVWUDWHG  WKDW  UH WUHDWPHQW  ZDV  VLJQL¿FDQWO\
                  higher in single fraction with OR ranging from 2.42 to 2.60. In terms of
                  VDIHW\  WKHUH ZDV QR VLJQL¿FDQW GLIIHUHQFH LQ WR[LFLWLHV EHWZHHQ WKH WZR

                                             39




          e-cpg inside text-Cancer pain-25/5/24.indd   39               09/08/2024   12:09 AM
   52   53   54   55   56   57   58   59   60   61   62